OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-10-31-accounts

Trustees' Annual Report for the period

Period start date Period start date Period end date Period end date
Day Month Year Day Month Year
**From ** 01 Nov 2021 To 31 Oct 2022

Section A Reference and administration details

Charity name Allez Charity Events Other names charity is known by Fireflies Europe Registered charity number (if any) 1164828 Charity's principal address Mount Pleasant Studios 51-53 Mount Pleasant London Postcode WC1X 0AE

Names of the charity trustees who manage the charity

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Trustee name Office (if any) Dates acted if not for whole
**year **
Name of person (or body) entitled
to appoint trustee (ifany)
Paul Adler
Richard Lewisohn
Chris Page
John Mawhood
Timothy McCoy-
Page
John Taylor
Names of the trustees for the charity, if any, (for example, any custodian trustees)
Name Dates acted if not for whole year

M h 2012

TAR

1

Names and addresses of advisers (Optional information)

Names and addresses of advisers (Optional information) Names and addresses of advisers (Optional information) Names and addresses of advisers (Optional information)
Type of adviser
Name
Address
Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing document Constitution dated 23 October 2015

How the charity is constituted Charitable Incorporated Organisation (eg. trust, association, company)

Trustee selection methods Appointed by agreement of the existing trustees, for a term of between (eg. appointed by, elected by) two and four years.

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

In selecting individuals for appointment as charity trustees, the existing charity trustees have regard to the skills, knowledge and experience needed for the effective administration of the CIO and will enhance this through induction and training where appropriate.

Section C Objectives and activities

The object of the CIO is to advance such charitable purposes (according to the law of England and Wales) as the trustees see fit from time to time in particular but not limited to the advancement of research into potential Summary of the objects of the cures and treatments of blood cancers, for the public benefit of those charity set out in its persons currently suffering from these diseases, and those who may in governing document the future be diagnosed with these diseases. The CIO will in particular but not exclusively organise fundraising events, and make donations or grants in furtherance of its object.

M h 2012

TAR

2

The trustees have had regard to the guidance issued by the Charity Commission on public benefit. The CIO makes one or more donations to carefully selected organisations, consistent with its object.

Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)

Research into potential cures and treatments for blood cancer provides a clear public benefit in reducing the risk of contracting diseases such as Leukaemia and Lymphoma, and increasing the possibility for patients to make a successful recovery. There are several renowned organisations operating in the UK, which have demonstrated through their research and clinical practice, substantially positive outcomes for patients and have communicated their know-how more widely, through peer-reviewed publications and conferences. They participate in important initiatives, which promote pan-European and other international collaboration in research and clinical excellence in treating blood cancers.

The section of the UK public who will benefit most from the work of our CIO is those persons who are currently suffering from a blood cancer, and those who may in the future be diagnosed with a blood-cancer related disease.

Additional details of objectives and activities (Optional information)

The trustees follow a thorough process to identify suitable recipient(s) of the funds that we raise: typically either another charity, which closely aligns with our object (ie. focused on cancer research) or for example a renowned research team associated with a hospital cancer treatment ward.

You may choose to include further statements, where relevant, about:

We go through both a vetting process, including visit(s) to potential recipient(s) where appropriate, and a verification process (post-donation) to receive feedback on how our donated funds have been used.

There is an annual review of the effectiveness of these processes and corrective steps are taken where necessary to ensure that the funds we have raised are used according to our declared object. We continue to communicate with Professor Jane Apperley, the principal of Imperial Health Charity (Blood Fund) and through the discussions have been able to review and verify the satisfactory use of the grant made during 2022, and look ahead to plans for 2023.

The CIO is entirely organised and staffed by volunteers, to whom we are very grateful. The trustees and others donate the use of premises and facilities required for our fundraising operations.

M h 2012

TAR

3

Section D Achievements and performance

Summary of the main achievements of the charity during the year

In the CIO’s seventh year of operation, donations totalling £500 were made to Imperial Health Charity (further designated for the Blood Fund); having been agreed by the trustees to be consistent with our object. This was facilitated in part by the generosity of John Mawhood, one of our trustees, who re-designated his original £200 loan to our charity as a donation.

A formal grant-making policy is yet to be developed, but would be based on the principles explained in the preceding paragraphs. The trustees remain at the heart of the decision-making process and other beneficiaries may be considered for future years.

Fundraising events have not yet been restarted, though we did continue to sell branded clothing. Insurance cover primarily relates to the cycling training (see below), which according to our assessment is the main risk. Due to timing differences for the payment of our insurance premium this year, it will fall into the 2023 FY. The trustees act as the main officers of the Fireflies Cycling Club.

The CIO was able to attract over 25 members to join the “Fireflies Cycling Club” which organises training for novice and improver cyclists enabling them to participate successfully and safely in endurance cycling events.

Meetings of the trustees were held virtually, including with sister groups around the world, which have similar objectives.

M h 2012

TAR

4

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date

M h 2012

TAR

5

1164828
Allez Charity Events
Receipts andpayments accounts
01/11/21
31/10/22
To
For the period
from
Allez Charity Events Allez Charity Events Allez Charity Events 1164828
For the period
from
01/11/21 To 31/10/22

CC16a

Section A Receipts and payments Section A Receipts and payments
Unrestricted
funds
to the nearest £
A1 Receipts
Charitable Donations
-
MembershipSubscriptions
375
Sales of Clothing (for Fundraising)
1,476
Incidental Sales at FundraisingEvents
-
Trustee Loans(Repayable)
-
HMRC Gift Aid Refund
-
-
-
Sub total(Gross income for AR)1,851
A2 Asset and investment sales,
(see table).
-
-
Sub total -
Total receipts 1,851
A3 Payments
Accounting& Website Software
249
Bank Fees
45
Charitable Donations - Imperial
Healthcare/Blood Fund
500
Payments to ClothingSuppliers
1,220
Insurance
Incidental Costs of FundraisingEvents
-
SundryPostage, Courier, Stationery
-
-
-
Sub total 2,014
A4 Asset and investment
purchases, (see table)
-
-
Sub total -
Total payments 2,014
Net of receipts/(payments)
- 163
A5 Transfers between funds
-
A6 Cash funds last year end
2,747
Cash funds this year end 2,584
Restricted funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Endowment
funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total funds
to the nearest £
Last year
to the nearest £
- -
630
1,736
-
-
-
-
2,366
375
1,476
-
-
-
-
-
1,851
- -
-
-
-
1,851 2,366
249 398
41
500
1,608
74
-
57
-
-
2,678
45
500
1,220
-
-
-
-
-
2,014
A4 Asset and investment
purchases, (see table)
- - -
- -
-
**Sub total ** -
Total payments
Net of receipts/(payments)
A5 Transfers between funds
A6 Cash funds last year end
**Cash funds this year end **
2,014 2,678
- 163 - - - 163 - 312
-
3,059
- **- ** - -
2,747 - - 2,747
2,584 - - 2,584 2,747

Section B Statement of assets and liabilities at the end of the period

Unrestricted Restricted funds Restricted funds Endowment
Categories Details funds funds
to nearest £ to nearest £ to nearest £
B1 Cash funds Balance at Barclays Bank 2,584 - -
- - -
- - -
Total cash funds 2,584 - -
(agree balances with receipts and payments
account(s)) OK OK OK
Unrestricted Restricted funds Endowment
funds funds
Details to nearest £ to nearest £ to nearest £
B2 Other monetary assets - - -
- - -
- - -
- - -
CCXX R1 accounts (SS) ~~1~~ ~~17/11~~/22

B3 Investment assets

B4 Assets retained for the charity’s own use

B5 Liabilities

Signed by one or two trustees on behalf of all the trustees

- - -
- - -
Details Fund to which asset
belongs
Cost (optional) Current value
(optional)
- -
- -
- -
- -
- -
Details Fund to which asset
belongs
Cost (optional) Current value
(optional)
Stock of merchandise retained for future unrestricted 220 150
fundraising sales - -
- -
- -
- -
- -
- -
- -
- -
Fund to which Amount due When due
Details liability relates (optional) (optional)
Balances due for Clothing Purchases -
Repayment of Trustee Loans 600 by agreement
-
-
-
Signature Print Name Date of approval

CCXX R2 accounts (SS)

17/11/22

2